Other Therapy Areas

Extending our scientific depth across allergy, dermatology, ophthalmology, respiratory, women's health, and more.

Learn More →

    Home > Events > Bio europe 2022

    1 min read

    BIO EUROPE Conference 2022 |    Booth #92

     Meet Veristat at the  Bio Europe Conference  2022 taking

    place on the  24th -26th  October 2022,  Booth #92

     

     

    Join Veristat and more than  2,500 professionals from biotech, pharma, finance, and life sciences industry across Europe’s most innovative biopharma clusters at the  Bio Europe Autumn 2022 event.

     

    Charlotte Smerdon, Veristat Cell & Gene Centre of Excellence Lead and Portfolio Director will be part of the Cell and Gene Panel taking place Monday 24th October at 1:00 PM  " From bench to beside: the unique clinical pathway of CGT products" 

     

    With more than 27 years of experience in clinical trial planning and execution, Veristat is equipped to support any development program.

    Whether you have a compound and need to get started on your IND, or want to recruit patients quickly to get your early phase trials running, or just need medical writing or biostatistical support for your programs - Veristat can help.   

    We provide impactful drug development and regulatory solutions on both a full-service or functional service basis.

     

    Schedule A Meeting

    Schedule a meeting by filling out the form on the right.   Find out how we can help you advance your next clinical trial or regulatory submission to successful outcomes.

     

    Conference Details

    Website: https://informaconnect.com/bioeurope/

    24th-26th October 2022 , Leipzig, Germany.

     

    Veristat Virtual Booth Image

     

     

     

     

    Share This Event:

       

    11 min read

    Monthly FDA Guidance and Regulatory News Review - September 2026

    This September 2026 regulatory update focuses on FDA’s new guidance on neonatal parenteral nutrition compounding and...

    8 min read

    Monthly FDA Guidance and Regulatory News Review - August 2026

    This August 2026 regulatory update focuses on the FDA finalizing three guidances addressing formal sponsor meetings,...